That empowers the relationship between manufactures & market specialists
We operate with innovative & synergistic portfolio to built specific programs.
Key differentiator factor, customized offers by KOL – Key Opinion Leaders.
Company focused on ensuring human food health through the control of specific bacterial pathogens in the production chain of proteins of animal origin.
Focus on ATM – Antimicrobial (AGP/ ATB) replacement market due current Antibiotic lack of efficacy pain for end customers.
This is not a regular transactional / distribution model: It’s a Shared risk (Profit & losses) Society of market specialists and manufactures (“win-win”).
Operate with a robust and innovative portfolio, supported by KOL / Renowned research institutions, delivering relevant value to the end customer.
Offer: Consultative selling; Customized programs; Additives blends
Operations Based on Brazil, accessing international market with commercial partnerships: Brazil, Latin America, USA
Commitment to high quality standards. Operating only with cutting-edge, sustainable technologies (eliminate the use of antibiotics).
Smart money: Operations evolving accordingly revenue growth, with aggressive sales performance bonus compensation.
